Literature DB >> 10964723

Cloning and characterization of human estrogen receptor beta promoter.

L C Li1, C C Yeh, D Nojima, R Dahiya.   

Abstract

Estrogen receptors beta (ERbeta) belong to the nuclear receptor superfamily of ligand-dependent transcription factors that play critical roles in regulating genes involved in a wide array of biological processes. To investigate regulation of tissue-specific expression of ERbeta, we cloned and characterized a 2.1-kilobase 5'-flanking region of the human ERbeta gene. Two major transcription start sites were identified by primer extension and rapid amplification of 5'-cDNA end. The human ERbeta proximal promoter contains both TATA box and initiator element (Inr) and is GC-rich with a GC content of 65%. An Alu repeat sequence containing an ER-dependent transcription enhancer exists between -1416 and -1703. The full-length 5'-flanking sequence of ERbeta fused to a luciferase reporter exhibited functional promoter activity in ERbeta-positive TSUPr1 cell, but not in ERbeta-negative DU145 cells. In addition, DNase I protection assays of the proximal promoter showed unique protection patterns with nuclear extracts from TSUPr1 cells and ERbeta negative HeLa cells, suggesting presence of cell-specific trans-acting factors that mediate tissue/cell-specific ERbeta expression. Serial deletion analysis revealed that a 293-bp region encompassing the TATA box and Inr element possesses basal promoter activity. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10964723     DOI: 10.1006/bbrc.2000.3363

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  34 in total

Review 1.  Estrogen receptor beta, a possible tumor suppressor involved in ovarian carcinogenesis.

Authors:  Gwendal Lazennec
Journal:  Cancer Lett       Date:  2006-01-18       Impact factor: 8.679

2.  Age- and cell cycle-dependent changes in EPC-1/PEDF promoter activity in human diploid fibroblast-like (HDF) cells.

Authors:  Toshihiko Kojima; Ken-ichi Nakahama; Kiyotaka Yamamoto; Hiroshi Uematsu; Ikuo Morita
Journal:  Mol Cell Biochem       Date:  2006-07-31       Impact factor: 3.396

3.  Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma.

Authors:  I Leav; K M Lau; J Y Adams; J E McNeal; M E Taplin; J Wang; H Singh; S M Ho
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

4.  Genistein increases estrogen receptor beta expression in prostate cancer via reducing its promoter methylation.

Authors:  Abeer M Mahmoud; Umaima Al-Alem; Mohamed M Ali; Maarten C Bosland
Journal:  J Steroid Biochem Mol Biol       Date:  2015-04-27       Impact factor: 4.292

5.  Clinical implications of ERβ methylation on sporadic breast cancers in Chinese women.

Authors:  Lin Zhao; Zhaojin Yu; Yunan Li; Xiaoyan Wen; Wenfeng Ma; Lin Wang; Jie Ren; Caigang Liu; Miao He; Xuefeng Bai; Mingli Sun; Zhihong Zheng; Xiaoyi Mi; Enhua Wang; Olufunmilayo I Olopade; Feng Jin; Minjie Wei
Journal:  Med Oncol       Date:  2011-11-22       Impact factor: 3.064

6.  Genetic polymorphisms of ESR1, ESR2, CYP17A1, and CYP19A1 and the risk of breast cancer: a case control study from North India.

Authors:  Shilpi Chattopadhyay; Sarah Siddiqui; Md Salman Akhtar; Mohammad Zeeshan Najm; S V S Deo; N K Shukla; Syed Akhtar Husain
Journal:  Tumour Biol       Date:  2014-01-16

7.  Effects of two common polymorphisms in the 3' untranslated regions of estrogen receptor beta on mRNA stability and translatability.

Authors:  Milica Putnik; Chunyan Zhao; Jan-Ake Gustafsson; Karin Dahlman-Wright
Journal:  BMC Genet       Date:  2009-09-15       Impact factor: 2.797

Review 8.  Hormone response in ovarian cancer: time to reconsider as a clinical target?

Authors:  Francesmary Modugno; Robin Laskey; Ashlee L Smith; Courtney L Andersen; Paul Haluska; Steffi Oesterreich
Journal:  Endocr Relat Cancer       Date:  2012-11-09       Impact factor: 5.678

9.  Genetic polymorphisms in the estrogen receptor beta (ESR2) gene and the risk of epithelial ovarian carcinoma.

Authors:  Galina Lurie; Lynne R Wilkens; Pamela J Thompson; Katharine E McDuffie; Michael E Carney; Keith Y Terada; Marc T Goodman
Journal:  Cancer Causes Control       Date:  2008-08-15       Impact factor: 2.506

Review 10.  The role of estrogen receptor β in prostate cancer.

Authors:  Paraskevi Christoforou; Panagiotis F Christopoulos; Michael Koutsilieris
Journal:  Mol Med       Date:  2014-10-02       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.